AppCorpus
Market US

DrDrugs: Guide for Physicians

by Skyscape Medpresso Inc

iPhone · iPad

Active Last checked 7 Aug 2026

Quick verdict

What it is
Store information collected; independent summary not yet available.
At a glance
  • Free to download
  • In-app purchases

Categories and search queries

Official categories

AppCorpus categories

Key functions

Function Availability Access Scope Evidence
Free app Yes Free Store published
In-app purchases Yes Limited free Store published

Screens

App Store

38 store screenshots

DrDrugs: Guide for Physicians ipad screenshot 1
DrDrugs: Guide for Physicians ipad screenshot 2
DrDrugs: Guide for Physicians ipad screenshot 3
DrDrugs: Guide for Physicians ipad screenshot 4

Pricing & paywalls

App Store

  • 15% off Limited Period offer — $33.49
  • 20% off Limited Period Offer — $31.49
  • 25% off Limited Period Offer — $29.49
  • Drug Guide for Physicians,17Ed — $49.99
  • Drug Guide-Physicians 1/M Sub — $3.99
  • Drug Guide-Physicians 1/Y Sub — $38.99

Ratings & reviews

App Store

4.5 33 ratings · App Store

  1. 5/5Very useful app!

    A very useful app with thousands of trade & generic drugs, 150 drug classifications and 800 built-in dosage calculators. The coolest feature is the audio pronunciations. This app provides audio pronunciations for over 800 generic drugs. Great content overall!

    Med_4_life · 7 Aug 2026

  2. 5/5Includes route and dosage calcs

    Many of the drug monographs include built in route & dosage calculators.

    Rustybag · 7 Aug 2026

  3. 1/5Not pleased, difficult to manouver.

    To difficult to find what I want. I wish I could quit this app.

    Doc QT · 7 Aug 2026

  4. 1/5Seriously??????

    Ask $49 for this app when you can find free or much, much cheaper (for few dollars) similar app. No way

    Alromac · 7 Aug 2026

Privacy & accessibility

App Store

Privacy

  • Data Not Linked to You — Analytics — Diagnostics — Crash Data Developer declared
  • Data Not Linked to You — Analytics — Identifiers — User ID Developer declared
  • Data Not Linked to You — Analytics — Search History Developer declared
  • Data Not Linked to You — Analytics — Usage Data — Product Interaction Developer declared
  • Data Not Linked to You — Analytics — User Content — Audio Data Developer declared
  • Data Not Linked to You — Developer’s Advertising or Marketing — Identifiers — User ID Developer declared
  • Data Not Linked to You — Third-Party Advertising — Identifiers — User ID Developer declared
  • Data Not Linked to You — Diagnostics Developer declared
  • Data Not Linked to You — Identifiers Developer declared
  • Data Not Linked to You — Search History Developer declared
  • Data Not Linked to You — Usage Data Developer declared
  • Data Not Linked to You — User Content Developer declared
  • Data Used to Track You — Identifiers — User ID Developer declared
  • Data Used to Track You — Identifiers Developer declared

Accessibility

No accessibility labels collected yet.

Versions

App Store

  • 1.7.160
  • 3.1.0

    - iPhone X Compatibility - UI/UX Enhancements - Minor bug fixes

  • 3.2.7

    NEW 2018 updates - iPhone X support - UI/UX enhancement - Minor bug fixes

  • 4..3

    Bug fixes related to new iOS and enhancements to Audio pronunciations.

  • 4.4.1

    Fixes related to connecting to iTunes for in-app purchases in iOS version 13.4 and above

  • 5.0.10

    2023 Update

  • 5.0.7

    - Minor bug fixes.

  • 5.0.8

    - New edition update. - Minor bug fixes.

  • 5.1.1

    Experience the full power of having 2024 Update of Davis's Drug Guide for Physicians in a mobile app, check out these feature releases: In this update we have added 24 new drug monographs including adapalene, anacaulase, bempedoic acid/ezetimibe, fostemsavir, naxitamabm, rifamycin, tivozanib, voclosporin, etc. We hae also revised and thoroughly updated 340+ drug monographs. - Read alerts under MedBeats relevant to your specialty - Audio notes: to quickly record notes on the go - Text notes: to record notes if you prefer - Zoom in or out on images with pinch action - Robust Indices for quick navigation like Image index & Table Index - Smart search: search content for a term or topic to find information quickly - History tracks your searches so you can revisit the topic when charting or care planning - Bookmark topics that you frequently access - Information relevant to Canadian students and nurses - Compare Canadian and U.S. pharmaceutical practices - Canada-only combination drugs in the Combination Drugs appendix - Additional Canadian brand names in the drug monographs - Added pharmacogenomic information throughout numerous monographs to guide the nurse in selecting and monitoring various drug therapies

  • 5.4.3

    Experience the full power of having 2024 Update of Davis's Drug Guide for Physicians in a mobile app, check out these feature releases: In this update we have added 24 new drug monographs including adapalene, anacaulase, bempedoic acid/ezetimibe, fostemsavir, naxitamabm, rifamycin, tivozanib, voclosporin, etc. We hae also revised and thoroughly updated 340+ drug monographs. - Read alerts under MedBeats relevant to your specialty - Audio notes: to quickly record notes on the go - Text notes: to record notes if you prefer - Zoom in or out on images with pinch action - Robust Indices for quick navigation like Image index & Table Index - Smart search: search content for a term or topic to find information quickly - History tracks your searches so you can revisit the topic when charting or care planning - Bookmark topics that you frequently access - Information relevant to Canadian students and nurses - Compare Canadian and U.S. pharmaceutical practices - Canada-only combination drugs in the Combination Drugs appendix - Additional Canadian brand names in the drug monographs - Added pharmacogenomic information throughout numerous monographs to guide the nurse in selecting and monitoring various drug therapies

  • 5.4.4

    More than 30 new drug monographs We have also revised and thoroughly updated 560+ drug monographs. 1,700 monographs and 5,000 trade name and generic drugs Highlighted REMS (Risk Evaluation and Mitigation Strategies) Drug-drug, drug-food, and drug-natural product interactions Special considerations for patient populations - Geri heading identifies special concerns for older adults, including the AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. - OB and Lact headings highlight information for pregnant and breastfeeding patients. - Pedi heading identifies concerns for children. - Rep heading identifies considerations for patients of reproductive age. IV Administration subheads Pharmacogenomic content

  • 5.6.4

    2025 Update

  • 5.7.1

    Get the best experience of connecting with communities, engaging with them with recent news, alerts, your favorite topics. Preview quick videos and watch them right on your devices. And in this release, we have also fixed bugs and made performance improvements. Just for you.

  • 5.7.4

    - Minor Bug fixes

  • 5.7.8

    - Minor Bug Fixes

  • 5.7.9

    Experience the full power of having 19th edition 2025 Update of Davis's Drug Guide for Physicians in a mobile app, check out these feature releases: - More than 90 new drug monographs including acoramidis, tafasitamab, rezafungin, vutrisiran etc - We have also revised and thoroughly updated 250+ drug monographs. - 1,700 monographs and 5,000 trade name and generic drugs - Highlighted REMS (Risk Evaluation and Mitigation Strategies) - Drug-drug, drug-food, and drug-natural product interactions - Audio notes: to quickly record notes on the go - Robust Indices for quick navigation like Image index & Table Index - Bookmark topics that you frequently access - IV Administration subheads - Added pharmacogenomic information throughout numerous monographs to guide the nurse in selecting and monitoring various drug therapies Special considerations for patient populations - Geri heading identifies special concerns for older adults, including the AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. - OB and Lact headings highlight information for pregnant and breastfeeding patients. - Pedi heading identifies concerns for children. - Rep heading identifies considerations for patients of reproductive age.

  • 5.8.0

    - Minor bug fixes

  • 5.8.5

    - Minor Bug Fixes

  • 5.8.6

    2026 Update

  • 5.9.2 · 17 Jun 2026

    20th Edition Updates: Fully revised with the latest drug approvals and guidelines for 2026. Newly added drug monographs, updated high-alert medication list, and current REMS safety information improve patient safety coverage. Contains all new and updated content reflecting changes in therapeutic uses, dosages, and adverse effect warnings since the previous edition. All clinical considerations are aligned with the latest standards of care, ensuring the most up-to-date guidance for safe medication prescribing and management.

Alternatives

Availability by market

Data quality & evidence

Page completeness
Live store listing
Last verified
7 Aug 2026
Sources
App Store

Report a correction